15.04.2025 • News

Cellasto Invests €60 million to Establish Second Plant in China

Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.

© BASF
© BASF

This production expansion aims to capitalize on China’s booming electric vehicle market. The new facility will feature advanced mold lines, resulting in a capacity increase of nearly 70%, with operations expected to start in 2027. A commencement ceremony was held on April 14 to celebrate this expansion.

“Cellasto has always delivered exceptional value to automotive manufacturers with the same passion for quality and efficiency. I am confident that this devotion will ensure a continued success with our customers in China in this vital automotive market,” commented Martin Jung, President of the Performance Materials Division, BASF.

“BASF has made substantial investments in China since entering the Chinese market 140 years ago.  Today’s expansion is another strong testament to BASF’s commitment to staying close to the local market and our customers. As the leading chemical supplier to the automotive industry, BASF strives to accelerate business growth in the automotive sector in China, by leveraging our local production network, strong innovation capabilities and deep market insights,” added Jeffrey Lou, President and Chairman Greater China, BASF.

“Four years ago, we celebrated Cellasto's 60th anniversary and the 10th anniversary of our Shanghai plant. This year, with the addition of a second plant, we are achieving another significant milestone. With our state-of-the-art facilities, we are eager to seize the opportunities presented by this dynamic market,” concludes Bjoern Kophstahl, Vice President of Cellasto.

Company

Logo:

BASF SE

Carl-Bosch-Straße 38
67056 Ludwigshafen
Germany

Company contact







Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read